BioCentury
ARTICLE | Clinical News

Virta reports data for continuous care intervention strategy for Type II diabetes

April 13, 2018 7:19 PM UTC

Data reported in Diabetes Therapy showed that the Virta Treatment intervention strategy from Virta Health Corp. (San Francisco, Calif.) safely reduced HbA1c, body weight and diabetes medication use in an open-label study in 349 Type II diabetics.

Virta Treatment comprises an individualized continuous care intervention strategy that includes a cellular-connected body weight scale, a finger-stick blood glucose and ketone meter, a blood pressure cuff if hypertension is diagnosed, access to web-based reporting and monitoring, education, communication with a remote care team consisting of a health coach and medical provider for advice and medication management, and social support through an online peer community...